InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Marshall Keith W. Director active across 1 company, notably Prometheus Biosciences, Inc.. In total, 7 reports have been published. Activity tracked since 9 December 2022. The latest transaction was disclosed on 2 June 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Marshall Keith W is an insider linked to Prometheus Biosciences, Inc., where he is Chief Financial Officer. The record shows 7 filings in total, and across the sampled recent filings from 2022-12-13 to 2023-06-16, the modal transaction nature is option exercise.